Trials / Active Not Recruiting
Active Not RecruitingNCT06448208
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
Definition of PET REsponSe CrItEria for Neuroendocrine Tumors (PRESCIENT)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
People with neuroendocrine cancer typically have imaging scans before and after treatment, including positron emission tomography (PET) scans. The scans are analyzed using a set of criteria that describes how the disease has responded to treatment. The purpose of this study is to establish new criteria for doctors to use when evaluating these PET scans. Researchers are testing whether these new criteria are useful for predicting whether a person's cancer gets better, gets worse, or stays the same. Researchers will also compare these new criteria to the current standard criteria for evaluating imaging scans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | positron emission tomography (PET) scans | Before and after treatment. |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-06-07
- Last updated
- 2026-03-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06448208. Inclusion in this directory is not an endorsement.